Altair Engineering (ALTR)
(Delayed Data from NSDQ)
$95.11 USD
-0.21 (-0.22%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $95.13 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$95.11 USD
-0.21 (-0.22%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $95.13 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Zacks News
Strength Seen in ChampionX (CHX): Can Its 10.4% Jump Turn into More Strength?
by Zacks Equity Research
ChampionX (CHX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Stratasys (SSYS) Forms Advisory Board for Additive Manufacturing
by Zacks Equity Research
Stratasys (SSYS) forms a fresh Customer Advisory Board to foster cooperation and creativity in additive manufacturing.
KBR Wins $61M Task Order to Support Defense Health Agency
by Zacks Equity Research
KBR's focus on high-end and differentiated government business work, strong margin performance, technology and consulting services is encouraging.
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
Howmet (HWM) to Benefit From Business Strength Amid Risks
by Zacks Equity Research
Howmet (HWM) stands to gain from strength in the commercial aerospace, and oil and gas markets. However, rising costs pose a threat to its profitability.
Quanta (PWR) Stock Rises 32.1% in 6 Months: More Room to Run?
by Zacks Equity Research
More demand for infrastructural solutions, renewable drive, buyouts and solid backlog aids Quanta (PWR). Yet the cyclicality of business ails.
Sterling's (STRL) Arm Receives $100M Data Center Project
by Zacks Equity Research
Sterling (STRL) banks on regular contract wins and solid project execution.
Stratasys (SSYS) Boosts Innovation With Arevo Acquisition
by Zacks Equity Research
Stratasys (SSYS) enhances its position in additive manufacturing by acquiring Arevo's technology portfolio.
Willdan (WLDN) Wins $46M Clark County School District Contract
by Zacks Equity Research
Willdan (WLDN) is set to transform Nevada's learning environment in the next 10 years.
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
ACM or ALTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACM vs. ALTR: Which Stock Is the Better Value Option?
Bull of the Day: Fluor (FLR)
by Shaun Pruitt
Flour Corporation's (FLR) stellar price performance over the last few years looks likely to continue into 2024 with its stock starting to check the boxes in many fundamental areas.
Stratasys (SSYS) Enhances Tumor Surgery With 3D-Printed Guides
by Zacks Equity Research
Stratasys (SSYS) contributes to the advancement of craniomaxillofacial tumor surgery at University Hospital Birmingham through the utilization of 3D-printed tailored surgical guides.
ACM vs. ALTR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACM vs. ALTR: Which Stock Is the Better Value Option?
Stratasys (SSYS) & Siemens Team Up to Enhance Medical Imaging
by Zacks Equity Research
Stratasys (SSYS) collaborates with Siemens Healthineers in a groundbreaking research initiative to propel advancements in medical imaging.
Sherwin-Williams (SHW) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Sherwin-Williams (SHW) delivered earnings and revenue surprises of 15.52% and 1.87%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Down -16.14% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down -18.35% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Altair Engineering (ALTR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Altair Engineering (ALTR) delivered earnings and revenue surprises of 25% and 1.68%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
AECOM (ACM) Wins 7-Year Deal to Design Cloudburst Strategies
by Zacks Equity Research
AECOM's (ACM) recent deal to support NYCDEP's cloudburst management program.
Altair (ALTR) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Altair (ALTR) benefits from strategic innovation investments, accretive acquisitions and solid market demand.
Altair Engineering (ALTR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Altair Engineering (ALTR) delivered earnings and revenue surprises of 24.14% and 5.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
VSE (VSEC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
VSE (VSEC) delivered earnings and revenue surprises of 48.21% and 6.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Sherwin-Williams (SHW) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Sherwin-Williams (SHW) delivered earnings and revenue surprises of 10.87% and 5.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ChampionX (CHX) Q1 Earnings Match Estimates
by Zacks Equity Research
ChampionX (CHX) delivered earnings and revenue surprises of 0% and 2.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?